What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001687509
Total reported value
$10.9B
$10.9B
72 檔
36.8%
During the Q3 2025 filing period, Rubric Capital Management LP (CIK: 0001687509) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $10.9B across 72 reported positions.
In Q3 2025, Rubric Capital Management LP displayed an active expansion posture, initiating 23 new positions and adding to 26 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TLN | Talen Energy CORP | Stock-Utilities | 17.29% | +0.52% | -20.05% | |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 10.52% | — | — | |
| 3 | FTAI | FTAI Aviation Ltd. | Stock-Industrials | 6.33% | +0.76% | -0.99% | |
| 4 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 5.62% | -0.03% | -5.19% | |
| 5 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 5.46% | -13.53% | EXIT | |
| 6 | GLNG | Golar LNG Limited | Stock-Energy | 4.19% | -1.06% | — | |
| 7 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 3.41% | +0.48% | -1.82% | |
| 8 | TAC | Transalta CORP | Stock-Other | 2.46% | +0.10% | — | |
| 9 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 2.29% | -0.07% | — | |
| 10 | FLR | Fluor CORP | Stock-Industrials | 2.14% | +2.41% | NEW | |
| 11 | MCY | Mercury General CORP | Stock-Other | 1.97% | -0.50% | — | |
| 12 | BGC | Bgc Group Inc-a | Stock-Financials | 1.92% | -0.08% | +5.85% | |
| 13 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 1.75% | +0.44% | +2.31% | |
| 14 | VTRS | Viatris Inc | Stock-Healthcare | 1.72% | +0.19% | +28.21% | |
| 15 | QDEL | Quidelortho CORP | Stock-Other | 1.54% | -0.05% | — | |
| 16 | AMRX | Amneal Pharmaceuticals Inc | Stock-Other | 1.39% | +0.16% | +5.33% | |
| 17 | EOSE | Eos Energy Enterprises Inc | Stock-Other | 1.32% | — | — | |
| 18 | RNW | ReNew Energy Global Plc | Stock-Other | 1.25% | +0.10% | — | |
| 19 | IART | Integra Lifesciences Holding | Stock-Other | 1.24% | +0.51% | +4.08% | |
| 20 | SDGR | Schrodinger Inc | Stock-Other | 1.19% | +0.23% | +5.38% | |
| 21 | COLL | Collegium Pharmaceutical Inc | Stock-Other | 1.12% | -0.03% | -10.49% | |
| 22 | ECVT | Ecovyst Inc | Stock-Other | 1.03% | -0.30% | +120.93% | |
| 23 | LBTYA | Liberty Global Ltd. | Stock-Other | 1.00% | -0.28% | +36.16% | |
| 24 | SSYS | Stratasys Ltd. | Stock-Other | 0.99% | -0.03% | — | |
| 25 | DK | Delek US Holdings Inc | Stock-Other | 0.98% | -0.03% | — | |
| 26 | LILA | Liberty Latin America Ltd. | Stock-Other | 0.98% | -0.32% | — | |
| 27 | BAX | Baxter International Inc | Stock-Healthcare | 0.97% | — | — | |
| 28 | ENOV | Enovis CORP | Stock-Other | 0.94% | +0.15% | — | |
| 29 | ZYME | Zymeworks Inc | Stock-Other | 0.91% | -0.18% | — | |
| 30 | TRVI | Trevi Therapeutics Inc | Stock-Other | 0.88% | -0.04% | — | |
| 31 | CMPR | Cimpress plc | Stock-Other | 0.84% | +0.37% | +110.32% | |
| 32 | OPK | Opko Health Inc | Stock-Other | 0.84% | +0.08% | — | |
| 33 | ADEA | Adeia Inc | Stock-Other | 0.81% | -0.45% | — | |
| 34 | NWL | Newell Brands Inc | Stock-Consumer Staples | 0.77% | +0.35% | — | |
| 35 | TDS | Telephone And Data Systems | Stock-Comm Services | 0.71% | -0.82% | EXIT | |
| 36 | MNKD | Mannkind CORP | Stock-Other | 0.69% | +0.61% | — | |
| 37 | GEO | Geo Group Inc/the | Stock-Other | 0.69% | +0.45% | +139.45% | |
| 38 | PRLB | Proto Labs Inc | Stock-Other | 0.63% | -0.21% | +8.62% | |
| 39 | NFE | New Fortress Energy Inc | Stock-Other | 0.62% | — | +1.50% | |
| 40 | OFIX | Orthofix Medical Inc | Stock-Other | 0.61% | -0.14% | — | |
| 41 | LBTYA | Liberty Global Ltd. | Stock-Other | 0.60% | -0.22% | +37.96% | |
| 42 | SPRY | Ars Pharmaceuticals Inc | Stock-Other | 0.51% | -0.05% | +247.52% | |
| 43 | MATV | Mativ Holdings Inc | Stock-Other | 0.51% | -0.09% | — | |
| 44 | CXW | Corecivic Inc | Stock-Other | 0.45% | +0.38% | +140.59% | |
| 45 | ALIT | Alight Inc - Class A | Stock-Other | 0.42% | — | -41.92% | |
| 46 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.41% | -0.13% | +8.94% | |
| 47 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.36% | -0.01% | — | |
| 48 | ANIP | Ani Pharmaceuticals Inc | Stock-Other | 0.35% | +0.20% | NEW | |
| 49 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.35% | +0.49% | — | |
| 50 | SCPH | Scpharmaceuticals Inc | Stock-Other | 0.33% | — | +10.86% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | FTAI | FTAI Aviation Ltd. | +1.1% | -0.99% | Add |
| 2 | PRLB | Proto Labs Inc | +0.6% | +8.62% | Add |
| 3 | TAC | Transalta CORP | +0.5% | — | Add |
| 4 | KNSA | Kiniksa Pharmaceuticals International, plc | +0.4% | +2.31% | Add |
| 5 | TRVI | Trevi Therapeutics Inc | +0.4% | — | Add |
| 6 | GEO | Geo Group Inc/the | +0.3% | +139.45% | Add |
| 7 | CXW | Corecivic Inc | +0.3% | +140.59% | Add |
| 8 | SPRY | Ars Pharmaceuticals Inc | +0.3% | +247.52% | Add |
| 9 | ANIP | Ani Pharmaceuticals Inc | +0.3% | +33.28% | Add |
| 10 | DK | Delek US Holdings Inc | +0.3% | — | Unchanged |
| 11 | ROIV | Roivant Sciences Ltd. | +0.2% | -1.82% | Add |
| 12 | MCY | Mercury General CORP | +0.2% | — | Add |
| 13 | MGTX | MeiraGTx Holdings plc | +0.1% | — | Add |
| 14 | SCPH | Scpharmaceuticals Inc | +0.1% | +10.86% | Add |
| 15 | MATV | Mativ Holdings Inc | +0.1% | — | Trim |
| 16 | TXMD | Therapeuticsmd Inc | 0% | — | Unchanged |
| 17 | EDSA | Edesa Biotech Inc | 0% | — | Unchanged |
| 18 | ZYME | Zymeworks Inc | 0% | — | Add |
| 19 | OPK 3.75 01-15-29Bond | Opko Health Inc | 0% | — | Unchanged |
| 20 | TH | Target Hospitality CORP | 0% | — | Add |
| 21 | ABUS | Arbutus Biopharma CORP | 0% | — | Trim |
| 22 | MYPS | Playstudios Inc | 0% | — | Trim |
| 23 | TSAT | Telesat CORP | 0% | — | Trim |
| 24 | SEG | Seaport Entertainment Group | -0.1% | — | Trim |
| 25 | EMBC | Embecta CORP | -0.1% | — | Trim |
| 26 | LBTYA | Liberty Global Ltd. | -0.1% | +37.96% | Add |
| 27 | SSYS | Stratasys Ltd. | -0.2% | — | Add |
| 28 | AMRX | Amneal Pharmaceuticals Inc | -0.2% | +5.33% | Add |
| 29 | ADEA | Adeia Inc | -0.2% | — | Trim |
| 30 | CNNE | Cannae Holdings Inc | -0.2% | -37.34% | Trim |
| 31 | LBTYA | Liberty Global Ltd. | -0.2% | +36.16% | Add |
| 32 | MREO | Mereo Biopharma Group Pl-adr | -0.3% | — | Unchanged |
| 33 | XPER | Xperi Inc | -0.3% | — | Unchanged |
| 34 | RNW | ReNew Energy Global Plc | -0.3% | — | Trim |
| 35 | INDV | Indivior Pharmaceuticals, Inc. | -0.3% | -75.66% | Trim |
| 36 | OFIX | Orthofix Medical Inc | -0.5% | — | Add |
| 37 | COLL | Collegium Pharmaceutical Inc | -0.5% | -10.49% | Trim |
| 38 | SDGR | Schrodinger Inc | -0.5% | +5.38% | Add |
| 39 | IART | Integra Lifesciences Holding | -0.6% | +4.08% | Add |
| 40 | OPK | Opko Health Inc | -0.6% | — | Trim |
| 41 | HRTX | Heron Therapeutics Inc | -0.6% | +8.94% | Add |
| 42 | ARQT | Arcutis Biotherapeutics Inc | -0.8% | — | Trim |
| 43 | BGC | Bgc Group Inc-a | -0.9% | +5.85% | Add |
| 44 | TEVA | Teva Pharmaceutical-sp Adr | -1.4% | -5.19% | Trim |
| 45 | ALIT | Alight Inc - Class A | -1.5% | -41.92% | Trim |
| 46 | GLNG | Golar LNG Limited | -1.9% | — | Add |
| 47 | QDEL | Quidelortho CORP | -2.3% | — | Trim |
| 48 | NFE | New Fortress Energy Inc | -3% | +1.50% | Add |
| 49 | TLN | Talen Energy CORP | -4.6% | -20.05% | Trim |
| 50 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
According to official SEC Form 13F filings, Rubric Capital Management LP reported a total U.S. public equity portfolio value of $10.9B across 72 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TLN, SPY, FTAI) accounted for 36.8% of total reported equity market value during Q3 2025.
Top New Position Initiated
SPY
市值: $932.7M
Top Position Liquidated / Trimmed
VST
前期市值: $111.1M
During Q3 2025, Rubric Capital Management LP's top holdings by market value included TLN (17.3%)、SPY (10.5%)、FTAI (6.3%). The largest single position, TLN, represented 17.3% of total portfolio value.
In Q3 2025, Rubric Capital Management LP made 82 total portfolio adjustments, initiating 23 new buys, adding to 26 positions, trimming 17 holdings, and fully liquidating 16 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.